Ocugen Stock News

I don't know if InvestorPlace's Larry Ramer is still short. But if he is, he's made a few bucks with OCGN stock down 23% in the past month.

Shares of Ocugen, Inc. (OCGN) fell 9. The post FDA Puts Ocugens Vaccine Candidate on Clinical Hold appeared first on Smarter Analyst .

Shares of Ocugen, Inc. (NASDAQ:OCGN) have been given an average recommendation of Hold by the six research firms that are covering the company, MarketBeat reports. Four investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have []

Ocugen, Inc. (OCGN) with the stream of -9.15% also noticed, India Barrick Gold Corporation (GOLD) encountered a rapid change of -0.05% in the last hour of Fridays trading session. Ocugen, The post Momentum Stock in Focus (ATR A Momentum Oscillator) ATR Alerts: Ocugen, Inc. (NASDAQ:OCGN), Barrick Gold Corporation (NYSE:GOLD) appeared first on Stocks Equity .

Black Friday Turns Red On "Terrible News" - Global Markets Crater On "Nu Variant" Panic The Friday after thanksgiving is called black Friday because that''s when retailers finally turn profitable for the year. Not so much for market, however, because this morning it''s red as far as the eye can see. The culprit: the same one we discussed late last night - the emergence of a new coronavirus strain detected in South Africa, known as B.1.1.529, which reportedly carries an "extremely high number" of mutations and is “clearly very different” from previous incarnations, which may drive further waves of disease by evading the body’s defenses according to South African scientists, and soon, Anthony Fauci. British authorities think it is the most significant variant to date and have hurried to impose travel restrictions on southern Africa, as did Japan, the Czech Republic and Italy on Friday. The European Union also said it aimed to halt air travel from the region. "Markets have been quite complacent about the pandemic for a while, partly because economies have been able to withstand the impact of selective lockdown measures.

The FDA has issued a clinical hold on Ocugen Inc''s (NASDAQ: OCGN ) Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152 (known as Covaxin outside the U.S.). The FDA plans to identify the specific deficiencies that are the basis for clinical hold and information on addressing those deficiencies. Related Link:

MALVERN, Pa., Nov. 26, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced that the U.S. Food and Drug Administration (FDA) has issued a clinical hold on the Companys Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152, known as COVAXIN outside the United States.

Gainers iSpecimen Inc. (NASDAQ: ISPC ) rose 56.9% to $16.00 in pre-market trading. The company recently announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments. Allied Healthcare Products, Inc. (NASDAQ: AHPI ) rose 29.6% to $6.98 in pre-market trading. Covid-related stocks surged on reports of new, heavily-mutated strain, feared to be more infectious than Delta variant. Valneva SE (NASDAQ: VALN ) rose 18.1% to $58.93 in pre-market trading. Valneva recently signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply up to 60 million doses of its inactivated COVID-19 vaccine candidate VLA2001, over two years. BIMI International Medical Inc. (NASDAQ: BIMI ) rose 16.9% to $0.8210 in pre-market trading. BIMI recently priced its private placement for $7.8 million in proceeds. Alpha Pro Tech, Ltd (NYSE: APT ) shares rose 15.2% to $5.90 in pre-market trading.

The FDA has issued a clinical hold on Ocugen Inc's (NASDAQ: OCGN) Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152 (known as Covaxin outside the U.S.).

The stock price of Ocugen Inc (NASDAQ: OCGN) increased by over 9% pre-market today. This is why it happened.

Three Fool.com contributors are bullish on Beyond Air, Ocugen, and Fulgent Genetics.